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IV were 25—34 years old (55.2%). Male patients were 87
60.8%) and females 36 (39.2%). Speciﬁc groups of infected
atients were customers of sex workers (32.2%), inject-
ng drug users (IDUs) (23.8%), female sex workers (19.6%),
ousewives (18.2%), children born from HIV positive mothers
4.9%), male sex workers (1.4%). Routes of transmission were
aginal sex (69.9%), shared needles use (22.4%), perinatal
4.9%), tattoo (2.1%), anal sex (0.7%). Stages of infection
hile diagnosed were stage IV (60.1%), stage I—III (39.9%).
ost patients came to hospital with opportunistic infections
72%), including pulmonary tuberculosis (50.5%), chronic
iarrhea due to parasitic infections (40.8%), oral candidiasis
16.5%). Patients on ARV treatment were 67 (46.9% of total
atients). Initial CD4 counts were 1 - 458. Most patients had
nitial CD4 counts < 50 (62.5%), while others with CD4 50—100
15.6%), 101—200 (9.4%), 201—350 (9.4%), > 350 (3.1%). Total
ortality was 44 (10 on ARV treatment, 34 had not got ARV).
Conclusion: The majority of HIV patients are young peo-
le 25—34 years old (55.2%). Vaginal sex is the main route
f transmission (69.9%), while shared needles use is 22.4%.
ost patients come to hospital in late stage (stage IV)
60.1%) that correlates with high mortality rate. Oppor-
unistic infections are found in 72% of patients when ﬁrst
iagnosed and the most common opportunistic infection is
ulmonary tuberculosis (50.5% of cases).
oi:10.1016/j.ijid.2010.02.1643
7.008
ile salt stimulated lipase genotype distribution in Ghana-
an couples discordant for HIV-1 infection
. Affram
University of Ghana Medical School, Accra, NA, Ghana
Background: Some individuals remain HIV-1 seronegative
espite multiple sexual exposures to HIV-1 virus. This study
nalyzed the possible role of bile salt stimulated lipase
BSSL) genotypes in the lack of HIV-1 transmission in Ghana-
an HIV-1 serologically discordant couples (SDCs). BSSL is
Lewis X-carrying glycoprotein secreted by the pancreas
nd present in human milk, the testes, adrenals and blood
lasma of humans. BSSL has been postulated to have variant
apacity to bind Dendritic cell-speciﬁc ICAM-3 grabbing non-
ntegrin (DC-SIGN) and potentially block viral transmission
cross a mucosal surface.
Methods: A total of 32 couples were enrolled in the study.
hese comprised of 12 SDCs and 20 serologically concor-
ant couples (SCC). Five milliliters of blood was taken from
ouples. HIV-1 antibody testing was done using Abbott HIV-
/2 Determine assay and conﬁrmed with Innolia HIV-1/HIV/2
ssay. HIV-1 negative serostatus of discordant negative part-
ers was conﬁrmed by polymerase chain reaction (PCR) and
SSL genotypes of all couples were also identiﬁed by PCR.
Results: HIV antibody testing with PCR conﬁrmation
evealed 8 SDC and 24 SCC. BSSL genotypes were grouped
nto high high (HH), high low (HL) and low low (LL) geno-
ypes based on the number of repeats (ranged from 6 to 19
epeats; 16 repeats or more was denoted as high (H) and less
han 16 repeats was low (L)). Each patient had 2 types of the
epeats. Fifty ﬁve percent of SDCs had HL genotype found to
e associated with strong binding of BSSL to DC-SIGN, 20%
0
s
n
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ad HH genotype and 25% had LL genotype both of which
re associated with weak binding of BSSL to DC-SIGN. On
he other hand, 40% of SCCs had HL genotype, 45% had LL
enotype and 15% had HH genotype. SDC positives were also
ompared to SCCs in terms of BSSL genotype distribution.
he HH genotypes in both groups were the same (15%). The
L genotype was higher in SDC positives (60%) than in SCCs
40%) and the LL genotypes was higher in SCCs (55%) than in
DC positive partners (25%).
Conclusion: SDCs could be more protected against HIV-1
ransmission from DC-SIGN to CD4 cells than SCCs.
oi:10.1016/j.ijid.2010.02.1644
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afety and immunogenicity of measles vaccine in HIV-
nfected children: Systematic review and meta-analysis
. Scott1,∗, W.J. Moss2, Z. Gilani 2, N. Low1
Institute of Social and Preventive Medicine, University of
ern, Berne, Switzerland
Bloomberg School of Public Health, Johns Hopkins Univer-
ity, Baltimore, MD, USA
Background: Measles vaccines could be less immunogenic
n immunosuppressed people. We conducted a system-
tic review to identify and synthesize evidence about the
mmunogenicity and safety of measles vaccination in HIV-
nfected children.
Methods: We searched eight electronic databases for
tudies published through February 12th 2009. Identiﬁed
tudies were independently screened by two reviewers for
ligibility based on predeﬁned criteria. Information was
xtracted independently by two reviewers. Meta-analysis
as conducted where appropriate, and heterogeneity in
esults between studies was investigated through stratiﬁ-
ation of results.
Results: Seven-hundred and twenty-three articles were
dentiﬁed. Twenty-ﬁve studies with comparison groups were
ncluded. Thirteen studies without comparison groups and
ne case report were also examined for adverse event
ata. After vaccination at 6 months, measles antibody levels
ere similar in HIV-infected and HIVunexposed (combined
elative risk (RR) 1.05, 95% conﬁdence interval (CI) 0.83-
.34) or HIVexposed but uninfected children (RR 0.91, 95%CI
.80-1.04). Among HIV-uninfected children, slightly more
IV-exposed but uninfected children responded when vac-
inated at 6 months than HIV-unexposed children (RR 1.11,
5%CI 0.99-1.25). By nine months of age, fewer HIV-infected
hildren responded to measles vaccine than HIVunexposed
RR 0.79, 95% CI 0.61-1.02,) or HIV-exposed but uninfected
hildren (RR 0.70, 95% CI 0.56-0.88). HIV-uninfected chil-
ren had similar levels of response after vaccination at nine
onths regardless their mother’s HIV-infection status (RR
.01, 95%CI 0.98-1.04). Vaccination at twelve months of age
esulted in poorer responses in HIV-infected children relative
o HIV-unexposed children (RR 0.52, 95% CI 0.21-1.33) and
IV-exposed but uninfected children (RR 0.61, 95% CI 0.50-
.73). No reference was made to adverse events in half the
tudies. In studies describing adverse events, most reported
o serious adverse events. There were limited data compar-
ng vaccinated to unvaccinated HIV-infected children.
